Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Drug therapy for methicillin-resistant Staphylococcus aureus.
Quintiliani R, Kuti J. Quintiliani R, et al. Conn Med. 2001 Jan;65(1):23-5. Conn Med. 2001. PMID: 11227621 Review. No abstract available.
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.
Kuti JL, Nightingale CH, Quintiliani R, Nicolau D. Kuti JL, et al. Diagn Microbiol Infect Dis. 2002 Sep;44(1):51-7. doi: 10.1016/s0732-8893(02)00416-9. Diagn Microbiol Infect Dis. 2002. PMID: 12376031
Economic benefit of a meropenem dosage strategy based on pharmacodynamic concepts.
Kuti JL, Maglio D, Nightingale CH, Nicolau DP. Kuti JL, et al. Am J Health Syst Pharm. 2003 Mar 15;60(6):565-8. doi: 10.1093/ajhp/60.6.565. Am J Health Syst Pharm. 2003. PMID: 12659058
Treatment of Clostridium difficile-associated disease (CDAD).
Florea NR, Kuti JL, Nightingale CH, Nicolau DP. Florea NR, et al. Conn Med. 2003 Mar;67(3):153-5. Conn Med. 2003. PMID: 12687790 Review. No abstract available.
Role of pharmacodynamics in designing dosage regimens for beta-lactams.
Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Kotapati S, et al. Conn Med. 2003 May;67(5):265-8. Conn Med. 2003. PMID: 12802841 Review. No abstract available.
197 results
Jump to page
Feedback